ÐÒÔË·Éͧ¼Æ»®

The Norwegian Cancer Society has recently allocated their 2024 grants to current cancer research projects. Eight researchers from Bergen made the final cut, including three from CCBIO.

Kari Strøno Wagner-Larsen defended November 15, 2024 her doctoral work at the University of Bergen with the thesis "Advanced MRI for developing more personalized treatment strategies in uterine cervical cancer". Wagner-Larsen's doctoral work includes four studies showing that traditional as well as advanced, computer-assisted MRI analyses (radiomics) improve the risk assessment of patients with... Read more

PhD students Shanshan Xu and Robin Mzati Sinsamala from the Greenness, Air Pollution, and health (GAP) research group attended the Urban Transitions 2024 conference held from 5-7 November in Sitges, Spain, an event closely aligned with the GAP´s focus on the health impacts of urban air pollution and greenness exposure.

Sign up for a free course in occupational health.

In Norway, approximately 500 new cases of thyroid cancer are diagnosed annually. About half of those diagnosed are less than 50 years old, and females constitute two thirds of the patients. The incidence of thyroid cancer is on the rise both in Norway and worldwide. Fortunately, the prognosis is quite good, and most patients are cured by surgery alone. Because the surgical treatment often... Read more

On October 28th, the Pandemic Centre arranged an international conference in Bergen. Professionals from a number of different institutions gathered to discuss topics like governance in complexity, AI, plantetary health and media-academic collaboration.

Vimentin, component of the cytoskeleton, has so far been associated with epithelial-to-mesenchymal transition, increased metastatic potential and, hence, poor prognosis in many cancer types. However, our newest study indicates that its role in endometrial cancer might be opposite to what we believed thus far.

Sturla Magnus Grøndal completed his PhD October 14, 2024 at the University of Bergen with his doctoral work "Mechanisms of Immune Dysregulation through AXL Receptor Tyrosine Kinase Signaling in Cancer and Fibrotic Diseases".